ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -8.0% | 1,162,072 | +7.8% | 0.00% | – |
| Q2 2022 | $263,000 | -13.5% | 1,077,599 | +0.9% | 0.00% | – |
| Q1 2022 | $304,000 | -44.6% | 1,068,118 | +8.9% | 0.00% | – |
| Q4 2021 | $549,000 | -45.3% | 980,612 | -0.5% | 0.00% | – |
| Q3 2021 | $1,004,000 | -30.8% | 985,253 | -6.2% | 0.00% | – |
| Q2 2021 | $1,450,000 | -49.0% | 1,050,806 | -37.1% | 0.00% | – |
| Q1 2021 | $2,841,000 | +87.0% | 1,671,558 | +36.4% | 0.00% | – |
| Q4 2020 | $1,519,000 | -19.3% | 1,225,684 | -7.6% | 0.00% | – |
| Q3 2020 | $1,883,000 | +24.3% | 1,326,504 | +5.9% | 0.00% | – |
| Q2 2020 | $1,515,000 | +11.3% | 1,252,107 | +8.6% | 0.00% | – |
| Q1 2020 | $1,361,000 | -70.4% | 1,153,393 | -47.1% | 0.00% | – |
| Q4 2019 | $4,602,000 | +108.2% | 2,181,368 | +117.1% | 0.00% | -100.0% |
| Q3 2019 | $2,210,000 | -11.7% | 1,004,597 | +1.5% | 0.00% | 0.0% |
| Q2 2019 | $2,504,000 | +16.0% | 990,044 | +59.5% | 0.00% | 0.0% |
| Q1 2019 | $2,159,000 | -2.2% | 620,557 | -35.1% | 0.00% | – |
| Q4 2018 | $2,208,000 | +65.8% | 956,698 | +176.4% | 0.00% | – |
| Q3 2018 | $1,332,000 | +58.0% | 346,097 | +38.4% | 0.00% | – |
| Q2 2018 | $843,000 | +86.1% | 250,005 | +15.8% | 0.00% | – |
| Q1 2018 | $453,000 | +3.7% | 215,834 | 0.0% | 0.00% | – |
| Q4 2017 | $437,000 | -55.9% | 215,834 | 0.0% | 0.00% | – |
| Q3 2017 | $992,000 | +163.8% | 215,834 | +23.1% | 0.00% | – |
| Q2 2017 | $376,000 | -47.2% | 175,262 | -22.5% | 0.00% | – |
| Q1 2017 | $712,000 | +24.7% | 226,156 | +2.9% | 0.00% | – |
| Q4 2016 | $571,000 | -30.9% | 219,833 | +3.4% | 0.00% | – |
| Q3 2016 | $826,000 | +49.6% | 212,568 | +3.5% | 0.00% | – |
| Q2 2016 | $552,000 | +5.1% | 205,291 | +20.2% | 0.00% | – |
| Q1 2016 | $525,000 | -17.5% | 170,734 | +3.3% | 0.00% | – |
| Q4 2015 | $636,000 | +54.0% | 165,307 | +22.0% | 0.00% | – |
| Q3 2015 | $413,000 | -24.4% | 135,544 | +5.1% | 0.00% | – |
| Q2 2015 | $546,000 | -5.7% | 128,938 | -14.1% | 0.00% | – |
| Q1 2015 | $579,000 | -41.4% | 150,177 | +2.2% | 0.00% | -100.0% |
| Q4 2014 | $988,000 | +33.5% | 146,902 | +8.9% | 0.00% | – |
| Q3 2014 | $740,000 | -42.3% | 134,841 | +7.7% | 0.00% | -100.0% |
| Q2 2014 | $1,283,000 | -13.4% | 125,216 | +1.4% | 0.00% | 0.0% |
| Q1 2014 | $1,482,000 | +21.7% | 123,436 | +14.6% | 0.00% | 0.0% |
| Q4 2013 | $1,218,000 | +7.4% | 107,726 | +2.3% | 0.00% | 0.0% |
| Q3 2013 | $1,134,000 | +59.0% | 105,273 | +36.9% | 0.00% | 0.0% |
| Q2 2013 | $713,000 | – | 76,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |